THE TEAM

The laboratory is based on the Unit of Biochemistry in the Faculty of Medicine from the Universitat de Barcelona, in the city center. The faculty is side-by-side with the Hospital Clínic de Barcelona, a reference worldwide in research and clinical practice.  The Faculty of Medicine is the perfect environment for students, researchers and clinicians to interact and collaborate to advance in science.


Picture from left to right: Dr. Leticia Pérez-Sisqués (former lab member), Gen´ís Campoy-Campos (PhD student), Almudena Chicote-González (PhD student), Dr. Cristina Malagelada, Dr. Julia Solana-Balaguer (it was her thesis defense day October 2023), Dr. Jordi Alberch (director of the Institute of Neuroscience) and Pol Garcia-Segura (PhD student).

GROUP MEMBERS

Cristina Malagelada Grau

Principal Investigator

cristina.malagelada@ub.edu



Almudena Chicote

PhD Student

almudena1997@gmail.com



Genís Campoy

FI-fellow PhD student

geniscampoy@hotmail.com


Pol García Segura

FPU- MINECO Predoctoral student

polgarse2@gmail.com


Visiting students

Master's students for 2024: 

- Mateo R. Bril from The University of Groningen  (The Netherlands) 

email: m.r.bril@student.rug.nl



- Gabriela Marinova from RUPRECHT-KARLS-UNIVERSITÄT, Heidelberg (Germany) 

email: gabbiimmarinowa@gmail.com



Final degree Project students for 2024:

-Inés Pérez Pérez 

email: iperezpe19@alumnes.ub.edu



-Èric Romera Carvajal

email: eromerca20@alumnes.ub.edu



-Maria Lázaro Clos

email: maria.lazaro@estudiants.urv.cat


FORMER MEMBERS


Júlia Solana

Postdoctoral researcher

julia.solbal@gmail.com

Núria Martín-Flores, PhD.

Postdoctoral fellow in Prof. Patricia Salinas' lab, in the Department of Cell and Developmental Biology, University College London, London, UK

khefre@msn.com

Leticia Pérez-Sisqués, PhD.

Post-doctoral research associate in Prof. Albert Basson Lab, King's College, London UK.

leticiaperezsisques@gmail.com

Ferran Soler Palazón

Master's student

fsolerpa40@alumnes.ub.edu

Marcel Vives Isern

Master's Student

mvives1304@gmail.com

Arnau Llobet Rosell

PhD Student in Dr. Lukas Neukomm's lab, Lausanne Switzerland

Mercè Canal de la Iglesia

Current position: PhD investigator at Hipra company (Girona, Spain)


Joan Romaní-Aumedes

Current position: Posdoctoral Fellow at École polytechnique fédérale de Lausanne (Switzerland)


Víctor Pérez Fernández

Current position: PhD Student at Western Sydney University (Australia)


Julián Bobis Camacho

Biomedical Sciences Undergraduate Student


Dr. Malagelada's CV summary:

I graduated and earned my Ph.D. in Biochemistry at the Autonomous University of Barcelona. During my thesis, I visited the laboratory of Dr. Mark P. Goldberg at Washington University in St. Louis (MO, USA) for three months. I defended my doctoral thesis in July 2003, obtaining the qualification of Excellent Cum Laude. From this period, I published 3 articles as first author in journals in the field of ischemia and neuroscience (Malagelada et al., Stroke 2004, Malagelada et al. Neurobiol of Dis., 2005 and Malagelada et al., Neurobiol of Dis., 2009) and three more papers as co-author.

In October 2003, I started my first postdoctoral stay in the group of Dr. Nikolaos Robakis at the Dpt. of Psychiatry from Mount Sinai School of Medicine in New York City (USA). In June 2004 I began my second postdoctoral stay in the group of Dr. Lloyd A. Greene, at Columbia University in New York, studying the RTP801 / REDD1 protein in Parkinson's disease (PD). We found that RTP801 induced neuronal death in PD cell and animal models, sequentially inactivating mTOR (Malagelada et al., JNeurosci, 2006) and Akt (Malagelada et al., JNeurosci, 2008). The pharmacological blocking of the induction of RTP801 with rapamycin was protective in cellular and animal models of PD (Malagelada et al., JNeurosci, 2010). Furthermore, RTP801 turned out to have a crucial function in the development of the telencephalon (Malagelada et al., JNeurosci, 2011). In 2008, I got my first "faculty appointment" as an Associate Research Scientist in the same department at Columbia University. In June 2009 I was awarded a Ramón y Cajal contract from MINECO, and in April 2010 I joined the Pharmacology Unit of the Faculty of Medicine of the University of Barcelona. In this department, I established my research group. In September 2015 I transferred my group to the Biochemistry Unit of the Dpt. of Biomedicine of the same faculty. In 2017, I won the competitive opening as an associate professor (profesora agregada) in the same department. I currently have a research project funded by MINECO (PID2020-119236RB-I00, 2020-2023) and another from the Michael J. Fox Foundation. I also have the participation of three pre-doctoral students: Genís Campoy-Campos (FI pre-doctoral fellow, thesis defense expected by June 2024), Almudena Chicote-González (MJFox Foundation predoctoral fellow, thesis defense expected by November 2024), and Pol Garcia-Segura (FPU fellow, expected thesis defense October 2026). From 2010 till now, we have been studying the contribution of RTP801/REDD1 to neurodegenerative disorders such as Parkinson's, Huntington's and Alzheimer's disease. We also have been studying the molecular mechanisms of both sporadic and LRRK2-related parkinsonisms in collaboration with the Hospital Clínic neurologists. Hence as an independent group from 2010, here are our achievements:

a) We have awarded with 5 research projects from MINECO (SAF2010-21058, SAF2014-45888-R, SAF2014-57160-R, SAF2017-88812-R and PID2020-119236RB-I00), a European Marie Curie Reintegration project (PIRG08-GA-2010-276957), and two US projects of the MJ Fox Foundation plus a predoctoral fellowship extension. We are part of the CIBERNED group of Dr. Jordi Alberch and members of a consolidated research group SGR of the Generalitat de Catalunya coordinated by Dr. Esther Pérez-Navarro;

b) We have published 21 research articles.

c) We have 1 article under review and two more papers under preparation, generated with the latest PID2020-119236RB-I00 project.

d) I have directed 8 doctoral theses of which, 5 have been defended with Excellent Cum Laude and the other three are in progress, 8 final degree projects, and 7 master's degrees in Neuroscience.

d) We have made two patent applications: the first was successfully transferred to AB Biotics and the second was abandoned.

UNIT OF BIOCHEMISTRY, Dept of Biomedicine, Casanova 143, 3rd floor, north wing, Faculty of Medicine, University of Barcelona 08036 Barcelona, Catalonia, Spain +34-934021919 
Powered by Webnode Cookies
Create your website for free!